{
  "image_filename": "table_p2_det_1_011.png",
  "image_path": "FlublokPI/extracted/figures/table_p2_det_1_011.png",
  "image_type": "Table",
  "page_number": 2,
  "block_id": "det_1_011",
  "claim_id": "claim_002",
  "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
  "supports_claim": false,
  "explanation": "Table presenting percentages of local (pain, redness, swelling, bruising) and systemic (headache, fatigue, muscle pain, nausea, joint pain, chills, fever) adverse events in two groups: Flublok (N=2272) and placebo (N=2231). does not support the claim because the table only reports adverse event rates for Flublok versus placebo and contains no information on cell- or egg-based vaccine production, mutations, or their impact on effectiveness",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "Table presenting percentages of local (pain, redness, swelling, bruising) and systemic (headache, fatigue, muscle pain, nausea, joint pain, chills, fever) adverse events in two groups: Flublok (N=2272) and placebo (N=2231).",
    "evidence_found": null,
    "reasoning": "does not support the claim because the table only reports adverse event rates for Flublok versus placebo and contains no information on cell- or egg-based vaccine production, mutations, or their impact on effectiveness",
    "confidence_notes": null
  }
}